Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) was downgraded by ValuEngine from a “buy” rating to a “hold” rating in a research report issued on Friday.

A number of other equities analysts have also weighed in on SBRA. Zacks Investment Research raised Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Wednesday, August 9th. Jefferies Group LLC raised Sabra Healthcare REIT from a “hold” rating to a “buy” rating and set a $25.00 target price on the stock in a research report on Tuesday, August 15th. BidaskClub lowered Sabra Healthcare REIT from a “sell” rating to a “strong sell” rating in a research report on Wednesday, August 16th. Finally, Stifel Nicolaus reaffirmed a “hold” rating and set a $26.00 target price on shares of Sabra Healthcare REIT in a research report on Friday, July 28th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $25.67.

Sabra Healthcare REIT (NASDAQ SBRA) traded up 1.78% during mid-day trading on Friday, hitting $22.24. 1,562,708 shares of the stock were exchanged. The stock has a 50 day moving average price of $22.50 and a 200 day moving average price of $24.86. The company has a market capitalization of $1.46 billion, a PE ratio of 18.72 and a beta of 0.89. Sabra Healthcare REIT has a 1-year low of $19.30 and a 1-year high of $29.10.

ILLEGAL ACTIVITY WARNING: “ValuEngine Downgrades Sabra Healthcare REIT, Inc. (SBRA) to Hold” was first published by American Banking News and is owned by of American Banking News. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The original version of this piece can be viewed at https://www.americanbankingnews.com/2017/09/02/valuengine-downgrades-sabra-healthcare-reit-inc-sbra-to-hold.html.

A number of large investors have recently added to or reduced their stakes in the stock. BlackRock Inc. raised its stake in Sabra Healthcare REIT by 9,246.7% in the first quarter. BlackRock Inc. now owns 9,293,011 shares of the real estate investment trust’s stock worth $259,556,000 after buying an additional 9,193,585 shares during the last quarter. OMERS ADMINISTRATION Corp bought a new stake in Sabra Healthcare REIT during the second quarter worth approximately $2,453,000. Stratos Wealth Partners LTD. bought a new stake in Sabra Healthcare REIT during the first quarter worth approximately $207,000. River Road Asset Management LLC raised its stake in Sabra Healthcare REIT by 30.2% in the second quarter. River Road Asset Management LLC now owns 2,314,827 shares of the real estate investment trust’s stock worth $55,787,000 after buying an additional 536,583 shares during the last quarter. Finally, APG Asset Management US Inc. bought a new stake in Sabra Healthcare REIT during the second quarter worth approximately $26,582,000. 99.26% of the stock is owned by institutional investors and hedge funds.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.